Non-viral biocompatible nanotechnology based strategies for siRNA/shRNA/AON delivery towards clinical development for Facioscapulohumeral muscular dystrophy therapeutics
Non-viral biocompatible nanotechnology based strategies for siRNA/shRNA/AON delivery towards clinical development for Facioscapulohumeral muscular dystrophy therapeutics